Gathering leading experts from Europe, the program will explore for the first day the intricate links between infection and inflammation, shedding light on how their interplay contributes to disease complications across the lifespan.
The second day will focus on innovations to prevent complications and resistance, culminating in a dedicated session on innovative treatments and vaccines that could transform future therapeutic approaches. Special sessions will also be held during the congress to present the research conducted as part of the CPER “Resist-omics” project.
Scientific pre-program:
Day 1: Complications of inflammatory and infectious diseases
Session 1: Infection and inflammation: Partners in crime
Keynote speaker: Mihai Netea (Radboud University, The Netherlands)
‘Trained immunity: long-term reprogramming of innate immune responses’
Speaker: Andreas Wack (The Francis Crick Institute, London, UK)
‘Long-term impact of acute respiratory infections on lung immunity: The macrophage perspective’
Session 2: Complications of inflammatory and infectious diseases
Keynote speaker: Filip Ottosson (Aalborg University’s, Denmark)
‘Inflammation and Beyond: IMIDs and the Cardiovascular System’
Speaker: Sabrina Marion (CIIL, Institut Pasteur de Lille, France)
‘Latent cerebral Toxoplasma gondii infection exacerbates pathophysiological mechanisms of Alzheimer’s disease’
Speaker: Rebekka Schneider-Kramann (Aachen University, Germany)
‘From inflammatory niches to fibrosis reversal: targeting stromal–immune crosstalk’
Session 3: Infection and inflammation: Age-related risks, complications and prevention strategies
Keynote speaker: Robbert Van der Most, infection, vaccination and risk of dementia: a proposed immunological model (Belgium)
Speaker: Laurent Martinez (Toulouse University, France)
Posters sessions
Day 2: Innovations to prevent or combat complications and resistance
Keynote speaker: Christina Düsing (University of Dusseldorf, Germany)
Emerging strategies for deep B cell depletion for the treatment of autoimmune diseases
Session 1: Prevention of inflammatory diseases
Speaker: Andrew Cope (Head of the Centre for Rheumatic Diseases in the Faculty of Life Sciences and Medicine at King’s College London, UK)
‘Rheumatoid arthritis’
Session 2: Innovative treatments and vaccines
Speaker: Yves Briers (Laboratory of Applied Biotechnology (L.A.B.), Ghent University – Belgium)
‘Engineering customized and microbiome-friendly phage-inspired antibiotics’
Speaker: Alain Baulard (CIIL, Institut Pasteur de Lille, France)
‘Alpibectir/Ethionamide (AlpE) – The Long and Winding Road to a New Therapeutic Concept’